Post-marketing Re-evaluation of WangBi Granules for Rheumatoid Arthritis

NCT05540938 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

340

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Wangbi granules
DRUG: Wangbi granules simulant

Sponsor

China-Japan Friendship Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]